Private equity group Advent International Corp. can’t rely on fallout from the pandemic to cancel a $1.9 billion acquisition of
Forescout argues the purchase agreement specifically bars Advent from citing the coronavirus as creating a “material adverse effect” that excuses the investment fund from finalizing the deal. Advent executives “expressly agreed to bear the risk of adverse impacts on the company from a pandemic,” Forescout’s lawyers said in the complaint, filed Tuesday.
The San Jose, California-based ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.